Nephro-Urology Monthly

Published by: Kowsar

Urinary Prognostic Biomarkers in Patients With Focal Segmental Glomerulosclerosis

Shiva Kalantari 1 , Mohsen Nafar 2 , 3 , 4 , * , Shiva Samavat 2 , 3 , 4 , Mostafa Rezaei-Tavirani 5 , Dorothea Rutishauser 6 , 7 and Roman Zubarev 6 , 7
Authors Information
1 Department of Basic Sciences, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Department of Nephrology, Shahid Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
3 Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
4 Chronic Kidney Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
5 Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
6 Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden
7 SciLifeLab, Stockholm, Sweden
Article information
  • Nephro-Urology Monthly: March 01, 2014, 6 (2); e16806
  • Published Online: March 9, 2014
  • Article Type: Research Article
  • Received: December 11, 2013
  • Revised: December 29, 2013
  • Accepted: January 2, 2014
  • DOI: 10.5812/numonthly.16806

To Cite: Kalantari S, Nafar M, Samavat S, Rezaei-Tavirani M, Rutishauser D, et al. Urinary Prognostic Biomarkers in Patients With Focal Segmental Glomerulosclerosis, Nephro-Urol Mon. 2014 ; 6(2):e16806. doi: 10.5812/numonthly.16806.

Abstract
Copyright © 2014, Nephrology and Urology Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. D'Agati V. The many masks of focal segmental glomerulosclerosis. Kidney Int. 1994; 46(4): 1223-41[PubMed]
  • 2. Fogo AB. Animal models of FSGS: lessons for pathogenesis and treatment. Semin Nephrol. 2003; 23(2): 161-71[DOI][PubMed]
  • 3. Benchimol C. Focal segmental glomerulosclerosis: pathogenesis and treatment. Curr Opin Pediatr. 2003; 15(2): 171-80[PubMed]
  • 4. Schnaper HW. Idiopathic focal segmental glomerulosclerosis. Semin Nephrol. 2003; 23(2): 183-93[DOI][PubMed]
  • 5. Chitalia VC, Wells JE, Robson RA, Searle M, Lynn KL. Predicting renal survival in primary focal glomerulosclerosis from the time of presentation. Kidney Int. 1999; 56(6): 2236-42[DOI][PubMed]
  • 6. Kalantari S, Rutishauser D, Samavat S, Nafar M, Mahmudieh L, Rezaei-Tavirani M, et al. Urinary prognostic biomarkers and classification of IgA nephropathy by high resolution mass spectrometry coupled with liquid chromatography. PLoS One. 2013; 8(12)[DOI][PubMed]
  • 7. Kalantari S, Nafar M, Rutishuser D. Predictive Urinary Biomarkers for Steroid-resistant and Steroid-sensitive Focal Segmental Glomerulosclerosis Using High Resolution Mass Spectrometry and Multivariate Statistical Analysis. PLOS ONE. 2013;
  • 8. Trygg J, Wold S. Orthogonal projections to latent structures (O-PLS). J Chemometric 2002; 16(3): 119-28[DOI]
  • 9. Hanamura K, Tojo A, Kinugasa S, Asaba K, Fujita T. The resistive index is a marker of renal function, pathology, prognosis, and responsiveness to steroid therapy in chronic kidney disease patients. Int J Nephrol. 2012; 2012: 139565[DOI][PubMed]
  • 10. Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011; 80(1): 17-28[DOI][PubMed]
  • 11. Humphrey RL, Karpetsky TP, Neuwelt EA, Levy CC. Levels of serum ribonuclease as an indicator of renal insufficiency in patients with leukemia. Cancer Res. 1977; 37(7 Pt 1): 2015-22[PubMed]
  • 12. Bellei E, Cuoghi A, Monari E, Bergamini S, Fantoni LI, Zappaterra M, et al. Proteomic analysis of urine in medication-overuse headache patients: possible relation with renal damages. J Headache Pain. 2012; 13(1): 45-52[DOI][PubMed]
  • 13. Costacou T, Ferrell RE, Ellis D, Orchard TJ. Haptoglobin genotype and renal function decline in type 1 diabetes. Diabetes. 2009; 58(12): 2904-9[DOI][PubMed]
  • 14. Flynn FV, Lapsley M, Sansom PA, Cohen SL. Urinary excretion of beta 2-glycoprotein-1 (apolipoprotein H) and other markers of tubular malfunction in "non-tubular" renal disease. J Clin Pathol. 1992; 45(7): 561-7[PubMed]
  • 15. Varghese SA, Powell TB, Budisavljevic MN, Oates JC, Raymond JR, Almeida JS, et al. Urine biomarkers predict the cause of glomerular disease. J Am Soc Nephrol. 2007; 18(3): 913-22[DOI][PubMed]
  • 16. Dennis GJ, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003; 4(5)[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments